Advanced Biomed Inc. (NASDAQ: ADVB)

Sector: Healthcare Industry: Diagnostics & Research CIK: 0001941029
P/B 2.81
P/E -2.50
P/S 0.00
Market Cap 8.45 Mn
ROIC (Qtr) -92.30
Div Yield % 0.00
Rev 1y % (Qtr) 0.00
Total Debt (Qtr) 30,869.00
Debt/Equity (Qtr) 0.01

About

Stock Price Chart

Analysis

Pros

  • Healthy cash reserves of 2.66M provide 95.10x coverage of short-term debt 27934, demonstrating strong liquidity position and minimal refinancing risk.
  • Strong tangible asset base of 6.24M provides 202.24x coverage of total debt 30869, indicating robust asset backing and low credit risk.
  • Cash reserves of 2.66M provide solid 13.91x coverage of other non-current liabilities 190959, indicating strong liquidity.
  • Cash reserves of 2.66M provide robust 0.87x coverage of current liabilities 3.04M, indicating strong short-term solvency.
  • Robust R&D investment of 964060 at 0.47x of SG&A 2.06M demonstrates strong commitment to innovation and future growth.

Cons

  • Investment activities of (13443) provide weak support for R&D spending of 964060, which is -0.01x, suggesting potentially insufficient investment in innovation relative to other capital deployment.
  • Free cash flow of (6.42M) provides weak coverage of capital expenditures of 13443, with a -477.51 ratio suggesting additional external financing needs for growth initiatives.
  • Operating earnings of (3.38M) show weak coverage of depreciation charges of 289604, with a -11.67 ratio indicating high capital intensity and potential reinvestment needs.
  • Free cash flow of (6.42M) represents just -7.23x of debt issuance 887963, suggesting concerning reliance on leverage rather than internal cash generation for growth.
  • Retained earnings of (19.62M) provide limited buffer against comprehensive income items of 1.26M, which is -15.63x, indicating elevated exposure to market risks.

Peer Comparison

Companies in the Diagnostics & Research
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 TMO Thermo Fisher Scientific Inc. 216.83 Bn 33.00 4.96 35.68 Bn
2 DHR Danaher Corp /De/ 162.47 Bn 46.38 6.69 16.86 Bn
3 IDXX Idexx Laboratories Inc /De 56.88 Bn 55.36 13.65 1.09 Bn
4 A Agilent Technologies, Inc. 39.82 Bn 32.64 5.87 3.41 Bn
5 IQV Iqvia Holdings Inc. 38.85 Bn 30.28 2.44 15.19 Bn
6 NTRA Natera, Inc. 31.32 Bn -101.29 14.80 0.18 Bn
7 MTD Mettler Toledo International Inc/ 28.99 Bn 34.68 7.35 2.21 Bn
8 WAT Waters Corp /De/ 22.92 Bn 35.32 7.38 1.49 Bn

Industry Comparisons

Current Valuation

Metric Value Industry Percentile
EV to Assets 0.55 2.69
EV to Cash from Ops. -0.54 18.14
EV to Debt 111.74 52.51
EV to EBIT -1.02 19.22
EV to EBITDA -1.26 4.35
EV to Free Cash Flow [EV/FCF] -0.54 2.84
EV to Market Cap 0.41 1.52
EV to Revenue 0.00 4.79
Price to Book Value [P/B] 2.81 1.34
Price to Earnings [P/E] -2.50 22.02

Dividend Metrics

Metric Value Industry Percentile
Dividend Coverage Ratio 0.00 -1.96
Dividend Payout Ratio % 0.00 2.83
Dividend per Basic Share 0.00 0.19
FCF Dividend Payout Ratio % 0.00 1.92
Interest Coverage 0.00 -126.58

Growth Metrics

Metric Value Industry Percentile
Capex Growth (1y) % 85.71 -31.50
Cash and Equivalents Growth (1y) % 0.36 21.37
Dividend Growth (1y) % 0.00 0.24
EBIAT Growth (1y) % -48.48 -55.24
EBITDA Growth (1y) % -23.83 -447.96
EBIT Growth (1y) % -48.48 -40.50
EBT Growth (1y) % -48.48 -70.94
EPS Growth (1y) % -45.45 -70.02
FCF Growth (1y) % -293.58 56.33
Gross Profit Growth (1y) % 0.00 185.11

Liquidity Ratios

Metric Value Industry Percentile
Asset Utilization Ratio 0.00 0.56
Cash Payout Ratio 0.00 0.01
Cash Ratio 0.87 1.21
Current Ratio 1.92 2.64
Debt to Equity Ratio 0.01 -0.80
Interest Cover Ratio 0.00 -126.58
Times Interest Earned 0.00 -126.58

Profitability

Metric Value Industry Percentile
EBITDA Margin % 0.00 -129.91
EBIT Margin % 0.00 -156.71
EBT Margin % 0.00 -162.23
Gross Margin % 0.00 47.70
Net Profit Margin % 0.00 -189.30